Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miquel Navasa

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Gastroenterologia Y Hepatologia|July 11, 2020
Liver transplant immunosuppression during the covid-19 pandemicXavier Forns, Miquel Navasa
Gastroenterologia Y Hepatologia|January 10, 2013
[Serum markers of liver fibrosis in patients with chronic hepatitis C infection. Prognostic value of noninvasive markers of fibrosis in liver transplantation]Gonzalo Crespo, Xavier Forns, Miquel Navasa
Journal of Hepatology|August 31, 2010
Retransplantation in patients with hepatitis C recurrence after liver transplantationJosé A Carrión, Miquel Navasa, Xavier Forns
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 21, 2016
Liver transplantation in SpainGloria de la Rosa, Constantino Fondevila, Miquel Navasa
Transplant International : Official Journal of the European Society for Organ Transplantation|June 9, 2011
Hepatic encephalopathy and post-transplant hyponatremia predict early calcineurin inhibitor-induced neurotoxicity after liver transplantationDomingo Balderramo, Jhon Prieto, Andrés Cárdenas, et al.
Gastroenterology|April 28, 2012
Viral hepatitis in liver transplantationGonzalo Crespo, Zoe Mariño, Miquel Navasa, et al.
Journal of Hepatology|December 3, 2014
Treatment options in patients with decompensated cirrhosis, pre- and post-transplantationMartina Gambato, Sabela Lens, Miquel Navasa, et al.
Hepatology (Baltimore, Md.)|January 22, 2011
Noninvasive assessment of liver fibrosisStella M Martínez, Gonzalo Crespo, Miquel Navasa, et al.
World Journal of Gastroenterology|August 30, 2014
Genetic variants of innate immune receptors and infections after liver transplantationGemma Sanclemente, Asuncion Moreno, Miquel Navasa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2019
Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipientsOlga Millán, Pablo Ruiz, Virginia Fortuna, et al.
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Gastroenterologia Y Hepatologia|July 11, 2020
Liver transplant immunosuppression during the covid-19 pandemicXavier Forns, Miquel Navasa
Gastroenterologia Y Hepatologia|January 10, 2013
[Serum markers of liver fibrosis in patients with chronic hepatitis C infection. Prognostic value of noninvasive markers of fibrosis in liver transplantation]Gonzalo Crespo, Xavier Forns, Miquel Navasa
Journal of Hepatology|August 31, 2010
Retransplantation in patients with hepatitis C recurrence after liver transplantationJosé A Carrión, Miquel Navasa, Xavier Forns
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 21, 2016
Liver transplantation in SpainGloria de la Rosa, Constantino Fondevila, Miquel Navasa
Transplant International : Official Journal of the European Society for Organ Transplantation|June 9, 2011
Hepatic encephalopathy and post-transplant hyponatremia predict early calcineurin inhibitor-induced neurotoxicity after liver transplantationDomingo Balderramo, Jhon Prieto, Andrés Cárdenas, et al.
Gastroenterology|April 28, 2012
Viral hepatitis in liver transplantationGonzalo Crespo, Zoe Mariño, Miquel Navasa, et al.
Journal of Hepatology|December 3, 2014
Treatment options in patients with decompensated cirrhosis, pre- and post-transplantationMartina Gambato, Sabela Lens, Miquel Navasa, et al.
Hepatology (Baltimore, Md.)|January 22, 2011
Noninvasive assessment of liver fibrosisStella M Martínez, Gonzalo Crespo, Miquel Navasa, et al.
World Journal of Gastroenterology|August 30, 2014
Genetic variants of innate immune receptors and infections after liver transplantationGemma Sanclemente, Asuncion Moreno, Miquel Navasa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2019
Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipientsOlga Millán, Pablo Ruiz, Virginia Fortuna, et al.
Pageof 11